Search research articles
Contact Us
Filters
Showing results (51-60 of 58) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 58 results.
NMR in Biomedicine
|
November 21, 2012
Classification of breast lesions pre-contrast injection using water resonance lineshape analysis
Abbie M Wood, Milica Medved, Ian D Bacchus, et al.
Magnetic Resonance in Medicine
|
July 6, 2004
Fourier components of inhomogeneously broadened water resonances in breast: a new source of MRI contrast
Milica Medved, Gillian M Newstead, Xiaobing Fan, et al.
Radiology
|
May 25, 2012
Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIAL
Nola M Hylton, Jeffrey D Blume, Wanda K Bernreuter, et al.
Radiology
|
December 2, 2015
Neoadjuvant Chemotherapy for Breast Cancer: Functional Tumor Volume by MR Imaging Predicts Recurrence-free Survival-Results from the ACRIN 6657/CALGB 150007 I-SPY 1 TRIAL
Nola M Hylton, Constantine A Gatsonis, Mark A Rosen, et al.
AJR. American Journal of Roentgenology
|
May 1, 2018
MRI, Clinical Examination, and Mammography for Preoperative Assessment of Residual Disease and Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer: ACRIN 6657 Trial
John R Scheel, Eunhee Kim, Savannah C Partridge, et al.
JAMA
|
February 26, 2020
Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts Undergoing Screening
Christopher E Comstock, Constantine Gatsonis, Gillian M Newstead, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
December 17, 2016
MR spectroscopy of breast cancer for assessing early treatment response: Results from the ACRIN 6657 MRS trial
Patrick J Bolan, Eunhee Kim, Benjamin A Herman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 30, 2018
Intensive Surveillance with Biannual Dynamic Contrast-Enhanced Magnetic Resonance Imaging Downstages Breast Cancer in <i>BRCA1</i> Mutation Carriers
Rodrigo Santa Cruz Guindalini, Yonglan Zheng, Hiroyuki Abe, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 58) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 58 results.
NMR in Biomedicine
|
November 21, 2012
Classification of breast lesions pre-contrast injection using water resonance lineshape analysis
Abbie M Wood, Milica Medved, Ian D Bacchus, et al.
Magnetic Resonance in Medicine
|
July 6, 2004
Fourier components of inhomogeneously broadened water resonances in breast: a new source of MRI contrast
Milica Medved, Gillian M Newstead, Xiaobing Fan, et al.
Radiology
|
May 25, 2012
Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIAL
Nola M Hylton, Jeffrey D Blume, Wanda K Bernreuter, et al.
Radiology
|
December 2, 2015
Neoadjuvant Chemotherapy for Breast Cancer: Functional Tumor Volume by MR Imaging Predicts Recurrence-free Survival-Results from the ACRIN 6657/CALGB 150007 I-SPY 1 TRIAL
Nola M Hylton, Constantine A Gatsonis, Mark A Rosen, et al.
AJR. American Journal of Roentgenology
|
May 1, 2018
MRI, Clinical Examination, and Mammography for Preoperative Assessment of Residual Disease and Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer: ACRIN 6657 Trial
John R Scheel, Eunhee Kim, Savannah C Partridge, et al.
JAMA
|
February 26, 2020
Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts Undergoing Screening
Christopher E Comstock, Constantine Gatsonis, Gillian M Newstead, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
December 17, 2016
MR spectroscopy of breast cancer for assessing early treatment response: Results from the ACRIN 6657 MRS trial
Patrick J Bolan, Eunhee Kim, Benjamin A Herman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 30, 2018
Intensive Surveillance with Biannual Dynamic Contrast-Enhanced Magnetic Resonance Imaging Downstages Breast Cancer in <i>BRCA1</i> Mutation Carriers
Rodrigo Santa Cruz Guindalini, Yonglan Zheng, Hiroyuki Abe, et al.
Page
of 6